SCHEMBL2305002

SCHEMBL2305002

CC(C)NC(=O)c1noc2cccnc12

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
LMNA P02545 2/20 0.47
HIF1A Q16665 5/20 0.43
NPC1 O15118 3/20 0.40
RAB9A P51151 3/20 0.40
TSHR P16473 1/20 0.40
SMN1; SMN2 Q16637 2/20 0.39
RIPK1 Q13546 1/20 0.39
KDM4E B2RXH2 2/20 0.39
DYRK1A Q13627 1/20 0.39
MLLT1 Q03111 1/20 0.39
ALDH1A1 P00352 2/20 0.38
MAPK1 P28482 1/20 0.38
MAOA P21397 1/20 0.38
MAOB P27338 1/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2307327 0.84 HIF1A (0.46) HIF1ARAB9ATSHRRIPK1ALDH1A1
SCHEMBL2307011 0.80 HSP90AB1 (0.44) LMNAHIF1ARAB9ATSHRRIPK1
SCHEMBL2310120 0.78 HIF1A (0.61) CYP1A2LMNAHIF1ASMN1; SMN2KDM4E
SCHEMBL4243185 0.77 KDM4E (0.47) CYP1A2LMNAHIF1ATSHRSMN1; SMN2
SCHEMBL24571662 0.73 CTSA (0.49) CYP1A2SMN1; SMN2RIPK1KDM4EMAPK1
SCHEMBL7451835 0.71 GRM4 (0.50) CYP1A2SMN1; SMN2RIPK1KDM4EDYRK1A
SCHEMBL14355563 0.70 KDM4E (0.61) LMNANPC1RAB9ATSHRSMN1; SMN2
SCHEMBL7451831 0.69 KDM4E (0.46) CYP1A2NPC1RAB9ATSHRSMN1; SMN2
SCHEMBL19531976 0.69 BRD4 (0.51) CYP1A2LMNASMN1; SMN2RIPK1KDM4E
SCHEMBL8101444 0.69 NPC1 (0.59) NPC1RAB9ASMN1; SMN2RIPK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2350077-A1 FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS AstraZeneca AB (SE) 2011-08-03 EP disclosed
WO-2010043893-A1 FUSED, SPIROCYCLIC HETEROAROMATIC COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS ASTRAZENECA AB (SE) 2010-04-22 WO disclosed